Key points are not available for this paper at this time.
Design
Editorial
Highlights the enormous economic costs of cardiovascular disease in low- and middle-income countries.
Cardiovascular disease (CVD) is the leading cause of death worldwide, causing ~31% of all deaths [ 1 ]. The economic costs of premature death and disability from CVD are enormous: between 2011 and 2025, the estimated financial loss due to CVD in LMICs was $3.7 trillion, representing 2% of GDP of LMICs on average [ 2 ].
No takes yet. Share an insight, caveat, or question.
Cohn et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: